“When you hear that six letter word: ‘cancer,’ you’re in the most horrible time you may ever be in,” says Robin Shah (R), here shown with Bobby Green (L) THYME CARE
Thyme Care is helping around 3,000 patients and plans to use the funds to scale its value-based care model.
When a patient is told they have been diagnosed with cancer, it can be both terrifying and confusing. From medical jargon to drug names to complicated procedures, they’re left with a barrage of information to interpret and retain. On top of that are their practical concerns about how to pay for treatment or even arrange transportation to their appointments. The sheer volume of things a patient has to juggle can be overwhelming, which can make it hard to ensure they receive proper care.
Robin Shah and Bobby Green want to simplify the process and help cancer patients navigate the complications of managing their disease. Their company, Thyme Care, aims to provide 24/7 support guiding patients to getting the care they need. On Monday, the company announced it has raised a $60 million Series B round co-led by Town Hall Ventures and Foresite Capital. The new infusion of capital brings the company’s total funding to $83 million.
